Torrent Pharma today said it has commenced production from its new plant in Gujarat, the first phase of which has come up at an investment of over Rs 650 crore.
The facility, which is being set up in two phases, is the company's 5th formulation plant and the second unit where active pharmaceutical ingredient would be produced, Torrent Pharmaceuticals said in a regulatory filing.
"The total investment made in the first phase of the plant is over Rs 650 crore," it added.
The new plant at Dahej SEZ is spread across 70 acres with a built up area of around 97,000 square meter. The first phase of the facility has an installed capacity of about 7,500 million tablets, capsules and 25 MT API per annum.
The plant will cater mainly to the more regulated international markets such as US, Brazil, Germany and is already approved by regulatory agencies of these countries, the company said.
"This plant will scale up Torrent's manufacturing capacity to meet the growing demand from the international markets," Torrent Pharma Executive Director Jinesh Shah said.
Construction of phase II will commence soon and once commissioned the total capacity will increase to about 14,000 million tablets/capsules and 80 Mt API per year, the company said.
Torrent Pharma stock closed at Rs 1,549.85, down 0.91 per cent, on the BSE.
